Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen in siRNA Agreement with AstraZeneca

NEW YORK, July 1 (GenomeWeb News) - Qiagen will supply siRNA molecules to AstraZeneca under an agreement announced today.


Financial details were not disclosed.


The products in the agreement were not part of the spinoff of Qiagen's DNA business, which was announced earlier (click here to see story).

The Netherlands-based Qiagen employs a proprietary design process based on TOM-amidites to produce its siRNA molecules.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.